Dr. Lal PathLabs Limited Bombay S.E.
Equities
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,630 INR | +0.16% | +2.95% | +2.18% |
14/05 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
13/05 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.69% | 786.18Cr | |
-7.18% | 250.48Cr | |
-41.95% | 233.09Cr | |
-11.99% | 181.86Cr | |
-21.18% | 150.68Cr | |
+17.44% | 121.55Cr | |
-43.89% | 114.27Cr | |
+14.89% | 96Cr | |
-9.93% | 95Cr |
- Stock Market
- Equities
- LALPATHLAB Stock
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Dr Lal PathLabs : Nomura Downgrades Dr Lal Pathlabs to Reduce From Neutral, Adjusts Price Target to 2,333 Indian Rupees From 2,155 Indian Rupees